{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:03Z","timestamp":1787772123498,"version":"build-2784847793"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Telogen effluvium (TE) is the most common cause of alopecia in women. Treatment should address the etiological factors and may include adjuvant therapies. In practice, physicians may employ modified approaches and utilize various combinations of topical and oral molecules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>In this real-life observational study, the aim was to evaluate the response of TE to iron supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The population consisted of all patients who sought consultation for TE at our dermatology department between March 2021 and February 2022. Eligible participants were women, aged between 18 and 65, having a clinical diagnosis of TE, and intended for treatment with iron supplementation. Exclusion criteria comprised current pregnancy, chronic or active inflammatory disease, newly discovered dysthyroidism, concurrent use of hair supplements, topical minoxidil, or any other medications. The response was assessed based on the patient\u2019s level of satisfaction, a significant indicator, given the substantial psychological impact of TE on women\u2019s daily lives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The analysis included 200 women. The average age was 32.9 \u00b1 11.4 years. A recent history of COVID-19 or treated dysthyroidism was present in 18.5% and 8% of patients, respectively, but did not impact their response. Significantly, patients with baseline ferritin \u226550 ng\/ml were mostly \u201cvery satisfied\u201d, those with baseline ferritin &lt;50 ng\/ml were mostly \u201cnot satisfied\u201d, and those with unknown levels were mostly \u201cpartially satisfied\u201d with iron supplementation. A high dose of elemental iron and a prolonged duration of treatment significantly improved the patients\u2019 level of satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Iron supplementation can improve the patient\u2019s level of satisfaction in TE even if serum ferritin is not low.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_744_22","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:04:44Z","timestamp":1711425884000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Iron Supplementation May Improve the Patient\u2019s Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study"],"prefix":"10.4103","author":[{"given":"Boutros","family":"Soutou","sequence":"first","affiliation":[{"name":"From the Dermatology Department, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph and H\u00f4tel-Dieu de France University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Rahme","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aren Joe","family":"Bizdikian","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Skaff","sequence":"additional","affiliation":[{"name":"From the Dermatology Department, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph and H\u00f4tel-Dieu de France University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Helou","sequence":"additional","affiliation":[{"name":"From the Dermatology Department, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph and H\u00f4tel-Dieu de France University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Tomb","sequence":"additional","affiliation":[{"name":"From the Dermatology Department, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Saint-Joseph and H\u00f4tel-Dieu de France University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CCID.S291170","article-title":"The Diagnostic value of serum ferritin for telogen effluvium:A cross-sectional comparative study","volume":"14","author":"Cheng","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2005.11.1104","article-title":"The diagnosis and treatment of iron deficiency and its potential relationship to hair loss","volume":"54","author":"Trost","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaad.2009.05.054","article-title":"Iron deficiency and diffuse nonscarring scalp alopecia in women:More pieces to the puzzle","volume":"63","author":"St Pierre","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.0412-5463.2001.00110.x","article-title":"Causes of hair loss and the developments in hair rejuvenation","volume":"24","author":"Rushton","year":"2002","journal-title":"Int J Cosmet Sci"},{"key":"R5-20240829","first-page":"507","article-title":"Low iron stores:A risk factor for excessive hair loss in non-menopausal women","volume":"17","author":"Deloche","year":"2007","journal-title":"Eur J Dermatol"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1523-1747.2003.12540.x","article-title":"Decreased serum ferritin is associated with alopecia in women","volume":"121","author":"Kantor","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-133-5-200009050-00008","article-title":"The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic","volume":"133","author":"Beutler","year":"2000","journal-title":"Ann Intern Med"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"e14761","DOI":"10.1111\/dth.14761","article-title":"Telogen effluvium associated with COVID-19 infection","volume":"34","author":"Olds","year":"2021","journal-title":"Dermatol Ther"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0968-0004(92)90249-9","article-title":"Ribonucleotide reductase:Regulation, regulation, regulation","volume":"17","author":"Elledge","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2009.12.006","article-title":"Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups","volume":"63","author":"Olsen","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1365-2133.2002.04997.x","article-title":"There is no clear association between low serum ferritin and chronic diffuse telogen hair loss","volume":"147","author":"Sinclair","year":"2002","journal-title":"Br J Dermatol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaad.2006.09.038","article-title":"Iron and hair loss in women;what is deficiency?This is the real question!","volume":"56","author":"Rushton","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_744_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:43Z","timestamp":1787769043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_744_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_744_22","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"2022-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}